Ellex Medical Lasers Ltd
Adelaide, Australia, 22 January 2010: Ellex Medical Lasers Limited (ASX: ELX), a global leader in the
design and manufacture of ophthalmic laser and ultrasound systems, today announced the launch of a
new yellow laser photocoagulator, Integre Yellow™, at the 33rd Annual Meeting of the Japanese
Society of Ophthalmic Surgeons (JSOS) in Tokyo.
The Integre Yellow™ is the first and only laser system to offer high-power 561nm yellow in a unique,
fully integrated design. The yellow wavelength is considered a more gentle and patient-friendly option
than other laser wavelengths used in ophthalmology to treat sight-threatening eye diseases, such as
diabetic retinopathy.
“Compared to traditional 514/532nm green wavelengths, 561nm yellow creates a more gentle retinal
burn and results in low scotoma (blind spot) formation. Most importantly, treatment can be performed
at lower energy settings, thereby improving patient comfort,” commented Ellex CEO, Simon Luscombe.
The yellow wavelength was first introduced in ophthalmology in argon-pumped dye laser systems.
These systems were bulky, required high levels of energy, and were expensive to maintain and service.
Modern-day laser systems offer the benefits of solid-state laser technology, but still require the use of
external fibers and connectors, which degrade overall system performance.
In contrast, the fully integrated design of the Integre Yellow™ provides improved working distance and
ergonomics in order to optimize practice efficiency, and completely eliminates the need for external
adapters or fibers. This unique, integrated design has been the key driver for the worldwide success of
the Ellex Integre® family of photocoagulators.
“With the introduction of the Integre Yellow™ we are confident of satisfying the need for an efficient,
reliable and ergonomic yellow laser system in the Japanese market, and of cementing Ellex’s position
as the leading ophthalmic technology provider in Japan,” said Mr. Luscombe.
The Integre Yellow™ will be launched at the Ellex exhibit during the JSOS in Tokyo, with US, European
and Australian releases scheduled for later in 2010.
ABOUT ELLEX
Ellex Medical Lasers Limited (ASX:ELX) designs, manufactures and markets a complete line of lasers
and diagnostic ultrasound systems used by ophthalmologists to diagnose and treat eye disease. With
more than 14,000 systems delivered to the market, Ellex has evolved since 1985 from a manufacturing
company of primarily OEM products, to direct marketing of its own branded products through subsidiaries in the United States, Japan, Germany and Australia, and a network of distribution partners
in more than 100 countries. In December 2006 Ellex acquired Innovative Imaging, a leading provider of
diagnostic ultrasound systems for ophthalmology, initiating the expansion of our product line beyond
lasers.
The Ellex name has long been synonymous with excellence in technology, in quality, and in customer
care. Ellex maintains the highest quality standards through product development and manufacturing,
and strives to provide unmatched levels of clinical expertise and support to our customers. All of these
efforts have combined to produce one of the highest levels of customer satisfaction in the ophthalmic
industry.
For additional information about Ellex and its products, please visit www.ellex.com
For further information on Ellex, please contact:
Simon Luscombe, CEO
Ellex Medical Lasers Limited
82 Gilbert Street, Adelaide, SA, 5000
W +61 8 8104 5293 | M +61 439 424 500
[email protected]
Victor Previn, Chairman
Ellex Medical Lasers Limited
82 Gilbert Street, Adelaide, SA, 5000
W +61 8 8104 5200 | M +61 414 661 994
[email protected]